{"pmid":32376320,"pmcid":"PMC7196539","title":"Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract.","text":["Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract.","Am J Obstet Gynecol","Cui, Pengfei","Chen, Zhe","Wang, Tian","Dai, Jun","Zhang, Jinjin","Ding, Ting","Jiang, Jingjing","Liu, Jia","Zhang, Cong","Shan, Wanying","Wang, Sheng","Rong, Yueguang","Chang, Jiang","Miao, Xiaoping","Ma, Xiangyi","Wang, Shixuan","32376320"],"journal":"Am J Obstet Gynecol","authors":["Cui, Pengfei","Chen, Zhe","Wang, Tian","Dai, Jun","Zhang, Jinjin","Ding, Ting","Jiang, Jingjing","Liu, Jia","Zhang, Cong","Shan, Wanying","Wang, Sheng","Rong, Yueguang","Chang, Jiang","Miao, Xiaoping","Ma, Xiangyi","Wang, Shixuan"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376320","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ajog.2020.04.038","keywords":["covid-19","sars-cov-2","exfoliated cell","lower female genital tract","vaginal fluid"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1666262687663783936,"score":9.490897,"similar":[{"pmid":32241022,"pmcid":"PMC7184332","title":"SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection.","text":["SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection.","BACKGROUND: Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is mainly spread through respiratory droplets or direct contact. But the infection condition of genital system is still unknown. This study aimed to evaluate whether or not SARS-CoV-2 is found in the vaginal fluid of women with COVID-19 illness. METHODS: 10 women with confirmed severe COVID-19 pneumonia admitted to in Tongji Zhongfa Hospital Intensive care union(ICU) ward from Feb 4, 2020 to Feb 24, 2020 were included. Clinical records, laboratory results, and computer tomography(CT)-scan examination were retrospectively reviewed. The evidence of genital infection potential was accessed by testing for the presence of SARS-CoV-2 in vaginal fluids obtained from vaginal swab samples. Reverse transcriptase polymerase chain reaction(RT-PCR) was used to confirm the SARS-CoV-2 infection in vaginal fluids. RESULTS: The clinical characteristics of these ten women were similar to those reported severe COVID-19 patients. All ten patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus. CONCLUSION: Findings from this small group of cases suggest that no SARS-CoV-2 virus existing in the vaginal fluids of severe COVID-19 patients.","Clin Infect Dis","Qiu, Lin","Liu, Xia","Xiao, Meng","Xie, Jing","Cao, Wei","Liu, Zhengyin","Morse, Abraham","Xie, Yuhua","Li, Taisheng","Zhu, Lan","32241022"],"abstract":["BACKGROUND: Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is mainly spread through respiratory droplets or direct contact. But the infection condition of genital system is still unknown. This study aimed to evaluate whether or not SARS-CoV-2 is found in the vaginal fluid of women with COVID-19 illness. METHODS: 10 women with confirmed severe COVID-19 pneumonia admitted to in Tongji Zhongfa Hospital Intensive care union(ICU) ward from Feb 4, 2020 to Feb 24, 2020 were included. Clinical records, laboratory results, and computer tomography(CT)-scan examination were retrospectively reviewed. The evidence of genital infection potential was accessed by testing for the presence of SARS-CoV-2 in vaginal fluids obtained from vaginal swab samples. Reverse transcriptase polymerase chain reaction(RT-PCR) was used to confirm the SARS-CoV-2 infection in vaginal fluids. RESULTS: The clinical characteristics of these ten women were similar to those reported severe COVID-19 patients. All ten patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus. CONCLUSION: Findings from this small group of cases suggest that no SARS-CoV-2 virus existing in the vaginal fluids of severe COVID-19 patients."],"journal":"Clin Infect Dis","authors":["Qiu, Lin","Liu, Xia","Xiao, Meng","Xie, Jing","Cao, Wei","Liu, Zhengyin","Morse, Abraham","Xie, Yuhua","Li, Taisheng","Zhu, Lan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32241022","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1093/cid/ciaa375","keywords":["covid-19 pneumonia","sars-cov-2","clinical features","vaginal fluid"],"locations":["tomography(CT)-scan"],"topics":["Diagnosis"],"weight":1,"_version_":1666138490252820480,"score":81.87361},{"pmid":32240079,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020.","We analyzed 2 clusters of 12 patients in Vietnam with severe acute respiratory syndrome coronavirus 2 infection during January-February 2020. Analysis indicated virus transmission from a traveler from China. One asymptomatic patient demonstrated virus shedding, indicating potential virus transmission in the absence of clinical signs and symptoms.","Emerg Infect Dis","Le, Thi Quynh Mai","Takemura, Taichiro","Moi, Meng Ling","Nabeshima, Takeshi","Nguyen, Le Khanh Hang","Hoang, Vu Mai Phuong","Ung, Thi Hong Trang","Le, Thi Thanh","Nguyen, Vu Son","Pham, Hong Quynh Anh","Duong, Tran Nhu","Nguyen, Hai Tuan","Ngu, Duy Nghia","Nguyen, Cong Khanh","Morita, Kouichi","Hasebe, Futoshi","Dang, Duc Anh","32240079"],"abstract":["We analyzed 2 clusters of 12 patients in Vietnam with severe acute respiratory syndrome coronavirus 2 infection during January-February 2020. Analysis indicated virus transmission from a traveler from China. One asymptomatic patient demonstrated virus shedding, indicating potential virus transmission in the absence of clinical signs and symptoms."],"journal":"Emerg Infect Dis","authors":["Le, Thi Quynh Mai","Takemura, Taichiro","Moi, Meng Ling","Nabeshima, Takeshi","Nguyen, Le Khanh Hang","Hoang, Vu Mai Phuong","Ung, Thi Hong Trang","Le, Thi Thanh","Nguyen, Vu Son","Pham, Hong Quynh Anh","Duong, Tran Nhu","Nguyen, Hai Tuan","Ngu, Duy Nghia","Nguyen, Cong Khanh","Morita, Kouichi","Hasebe, Futoshi","Dang, Duc Anh"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240079","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3201/eid2607.200591","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","vietnam","presymptomatic","respiratory infections","severe acute respiratory syndrome coronavirus 2","travelers","viruses","zoonoses"],"locations":["Vietnam","China","Vietnam"],"countries":["Viet Nam","China"],"countries_codes":["VNM|Viet Nam","CHN|China"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1666138490416398336,"score":66.25604},{"pmid":32292802,"pmcid":"PMC7138902","title":"Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","text":["Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.","Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.","Virusdisease","Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama","32292802"],"abstract":["Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus."],"journal":"Virusdisease","authors":["Islam, Arshi","Ahmed, Anwar","Naqvi, Irshad H","Parveen, Shama"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292802","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s13337-020-00575-1","keywords":["covid-19","china","emergence","global transmission","sars-cov-2","wuhan city"],"locations":["Wuhan","Hubei","China","Wuhan","China","Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Transmission","Treatment","Diagnosis"],"weight":1,"_version_":1666138494325489664,"score":64.18214},{"pmid":32400235,"title":"The role of lower respiratory tract samples in the diagnosis of COVID-19.","text":["The role of lower respiratory tract samples in the diagnosis of COVID-19.","Infect Dis (Lond)","Williams, Tom G S","Snell, Luke B","Taj, Usman","Douthwaite, Sam T","32400235"],"journal":"Infect Dis (Lond)","authors":["Williams, Tom G S","Snell, Luke B","Taj, Usman","Douthwaite, Sam T"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32400235","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/23744235.2020.1761999","topics":["Diagnosis"],"weight":1,"_version_":1666714494854758402,"score":63.894756},{"pmid":32403141,"title":"Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.","text":["Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.","OBJECTIVE: The aim of this study is to summarize currently available evidence on vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). STUDY DESIGN: A systematic review was conducted following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis Statement. RESULTS: A total of 22 studies comprising 83 neonates born to mothers diagnosed with coronavirus disease 2019 were included in the present systematic review. Among these neonates, three were confirmed with SARS-CoV-2 infection at 16, 36, and 72 hours after birth, respectively, by nasopharyngeal swab real-time polymerase chain reaction (RT-PCR) tests; another six had elevated virus-specific antibody levels in serum samples collected after birth, but negative RT-PCR test results. However, without positive RT-PCR tests of amniotic fluid, placenta, or cord blood, there is a lack of virologic evidence for intrauterine vertical transmission. CONCLUSION: There is currently no direct evidence to support intrauterine vertical transmission of SARS-CoV-2. Additional RT-PCR tests on amniotic fluid, placenta, and cord blood are needed to ascertain the possibility of intrauterine vertical transmission. For pregnant women infected during their first and second trimesters, further studies focusing on long-term outcomes are needed. KEY POINTS: . We review neonates of mothers diagnosed with coronavirus disease 2019 detected by real-time polymerase chain reaction (RT-PCR).. . No direct virologic evidence of vertical transmission has been reported.. . No evidence that cesarean delivery is safer than vaginal delivery.. . More RT-PCR tests on amniotic fluid, placenta, and cord blood are recommended..","Am J Perinatol","Yang, Ziyi","Liu, Yi","32403141"],"abstract":["OBJECTIVE: The aim of this study is to summarize currently available evidence on vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). STUDY DESIGN: A systematic review was conducted following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis Statement. RESULTS: A total of 22 studies comprising 83 neonates born to mothers diagnosed with coronavirus disease 2019 were included in the present systematic review. Among these neonates, three were confirmed with SARS-CoV-2 infection at 16, 36, and 72 hours after birth, respectively, by nasopharyngeal swab real-time polymerase chain reaction (RT-PCR) tests; another six had elevated virus-specific antibody levels in serum samples collected after birth, but negative RT-PCR test results. However, without positive RT-PCR tests of amniotic fluid, placenta, or cord blood, there is a lack of virologic evidence for intrauterine vertical transmission. CONCLUSION: There is currently no direct evidence to support intrauterine vertical transmission of SARS-CoV-2. Additional RT-PCR tests on amniotic fluid, placenta, and cord blood are needed to ascertain the possibility of intrauterine vertical transmission. For pregnant women infected during their first and second trimesters, further studies focusing on long-term outcomes are needed. KEY POINTS: . We review neonates of mothers diagnosed with coronavirus disease 2019 detected by real-time polymerase chain reaction (RT-PCR).. . No direct virologic evidence of vertical transmission has been reported.. . No evidence that cesarean delivery is safer than vaginal delivery.. . More RT-PCR tests on amniotic fluid, placenta, and cord blood are recommended.."],"journal":"Am J Perinatol","authors":["Yang, Ziyi","Liu, Yi"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32403141","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1055/s-0040-1712161","locations":["swab","placenta","fluid","placenta","placenta"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1666714494940741632,"score":62.87628}]}